Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹946.75up ₹22.95 (2.48%)BSE ₹946.65
Share price at the NSE close on 2 Nov 2026. Previous close ₹923.80.
2 Nov: open ₹925.00, high ₹949.90, low ₹919.00
52-week range of traded prices to 2 Nov 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Next results date: the board meets on 13 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,080 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.83
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 36.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.13
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,48,07658.1% delivered
Jubilant Pharmova share news and announcements
1,153 announcements, routine notices left out, newest first. Page 16 of 24.
Sep 2015
Aug 2015
Jul 2015
10 Jul · Legal
Significant volume movement has been observed in Jubilant Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jubilant Life Sciences Limited has vide its letter inter-alia stated, "that we do not have any information under clause 36 of the Listing Agreement or otherwise to disclose/share with the stock exchanges."
Jun 2015
May 2015
12 May · Dividend
Board of Directors at its meeting held on May 12, 2015, has recommended a dividend of Rs. 3 per equity share of Rs. 1 fully paid up amounting to Rs. 5751 lacs (including dividend distribution tax), subject to approval in the Annual General Meeting.
Apr 2015
Mar 2015
31 Mar · Disclosure of Voting Pattern - Clause 35A
Feb 2015
20 Feb · Management
Mr. Rajiv Shah has been appointed as Company Secretary of the Company w.e.f. February 16, 2015. He shall also be the Compliance Officer of the Company.
Jan 2015
23 Jan · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014.
Dec 2014
Nov 2014
Oct 2014
20 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2014.
Sep 2014
9 Sep · Disclosure of Voting Pattern - Clause 35A
9 Sep · Disclosure of Voting Pattern - Clause 35A
3 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2014
8 Aug · Meeting
Company has fixed Book Closure from August 23, 2014 to September 2, 2014 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on September 2, 2014 and declaration of dividend subject to the approval of members in the AGM.
Jul 2014
25 Jul · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2014.
Jun 2014